Articles Vol. 67 No. 6 25/06/2026

LONG-TERM OUTCOME OF RIGHT HEPATECTOMY WITH SELECTIVE CONTROL OF THE RIGHT HEPATIC PEDICLE FOR HEPATOCELLULAR CARCINOMA AT VIETNAM NATIONAL CANCER HOSPITAL

Trinh Huy Phuong1,2, Nguyen Van Dang1,2,3,4, Pham The Anh1,2,3,4
1 Department of Hepatobiliary and Pancreatic Surgery, K Hospital
2 Khoa Ngoại Gan mật tụy, Bệnh viện K
3 Hanoi Medical University
4 Trường Đại học Y Hà Nội
DOI: 10.52163/yhc.v67i6.5475
24 Views
14 Downloads
Keywords
hepatocellular carcinoma, right hepatectomy, selective control of the right hepatic pedicle.
Abstract

Objective: To evaluate the results of right hepatectomy with selective control of the right hepatic pedicle for hepatocellular carcinoma (HCC). Subjects and methods: Retrospective descriptive study on 131 patients undergoing right hepatectomy with selective control of the right hepatic pedicle for HCC at the Department of Hepatobiliary and Pancreatic Surgery, Vietnam National Cancer Hospital, from January 2020 to December 2024. Results: The mean age was 55.2 ± 12.2 years; 78.6% were HBsAg-positive; tumors > 5 cm accounted for 76.3%; solitary tumors for 87.8%; and moderately differentiated tumors for 57.3%. Selective right pedicle control was achieved using the Takasaki approach in 85.5% of patients. No 30-day postoperative mortality was recorded. Mean overall survival was 55 ± 2.5 months, and mean disease-free survival was 43.3 ± 2.8 months. AFP > 400 ng/mL and tumor differentiation were associated with OS, whereas no statistically significant association was observed with DFS. Tumor size > 5 cm and tumor number were not significantly associated with OS or DFS. Conclusion: Right hepatectomy with selective control of the right hepatic pedicle is a safe and effective treatment for appropriately selected patients with HCC. The 5-year overall survival rate was 65,3%.

References
[1]
Asafo-Agyei KO, Samant H. Hepatocellular Carcinoma. StatPearls. 2025. Google Scholar
[2]
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today (Version 1.1). Lyon, France: International Agency for Research on Cancer 2024. Google Scholar
[3]
Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị ung thư biểu mô tế bào gan. 2020. Google Scholar
[4]
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatocellular Carcinoma. Version 1.2025. Plymouth Meeting, PA: NCCN; 2025. Google Scholar
[5]
Andreou A, Vauthey JN, Cherqui D, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. Jan 2013;17(1):66-77; discussion p 77. DOI: 10.1007/s11605-012-2005-4 Google Scholar
[6]
Takasaki K. Newly developed systematized hepatectomy by Glissonean pedicle transection method. Shujutsu. 1986;40:7-14. DOI: 10.1007/s005340050047 Google Scholar
[7]
Tôn Thất Tùng. Cắt Gan. Nhà xuất bản khoa học và kỹ thuật; 1971:1-291. Google Scholar
[8]
Piccus R, Joshi K, Hodson J, et al. Significance of predicted future liver remnant volume on liver failure risk after major hepatectomy: a case matched comparative study. Front Surg. 2023;10:1174024. DOI: 10.3389/fsurg.2023.1174024 Google Scholar
[9]
Trịnh Quốc Đạt. Nghiên cứu ứng dụng kỹ thuật kiểm soát chọn lọc cuống Glisson trong cắt gan điều trị ung thư tế bào gan. Luận án Tiến sĩ Y học - Đại học Y Hà Nội. 2019. Google Scholar
[10]
Vũ Văn Quang. Nghiên cứu ứng dụng kỹ thuật kiểm soát cuống Glisson theo Takasaki trong cắt gan điều trị ung thư biểu mô tế bào gan tại Bệnh viện Trung ương Quân đội 108. Luận án tiến sĩ Y học. 2019. Google Scholar
[11]
Mouly C, Fuks D, Browet F, et al. Feasibility of the Glissonian approach during right hepatectomy. HPB (Oxford). Aug 2013;15(8):638-45. DOI: 10.1111/hpb.12035 Google Scholar
[12]
Chen J, Li H, Liu F, Li B, Wei Y. Surgical outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma for various resection extent. Medicine. 2017;96(12). DOI: 10.1097/MD.0000000000006460 Google Scholar
[13]
Jaeck D, Bachellier P, Oussoultzoglou E, Weber J-C, Wolf P. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: An overview. Liver Transplantation. 2004/02/01 2004;10(S2):S58-S63. DOI: 10.1002/lt.20041 Google Scholar
[14]
European Association for the Study of the L. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. Feb 2025;82(2):315-374. Google Scholar
[15]
Lê Văn Thành. Nghiên cứu chỉ định và kết quả phẫu thuật cắt gan kết hợp phương pháp Tôn Thất Tùng và Lortat Jacob trong điều trị ung thư biểu mô tế bào gan. Luận án tiến sĩ Y học - Học viện Quân Y. 2013. Google Scholar
[16]
Ding HF, Zhang XF, Bagante F, et al. Prediction of tumor recurrence by alpha-fetoprotein model after curative resection for hepatocellular carcinoma. Eur J Surg Oncol. Mar 2021;47(3 Pt B):660-666. DOI: 10.1016/j.ejso.2020.10.017 Google Scholar